Evidence map›Paper›PMID 32409640›Full record

ArticleCommunications biology2020

Influenza infection rewires energy metabolism and induces browning features in adipose cells and tissues.

Asma Ayari, Manuel Rosa-Calatrava, Steve Lancel, Johanna Barthelemy, Andrés Pizzorno, Alicia Mayeuf-Louchart, Morgane Baron, David Hot, Lucie Deruyter, Daphnée Soulard and 9 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. FGF21 acting on the noradrenergic nervous system protects against influenza virus infection.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. The immunology of sickness metabolism.Cellular & molecular immunology · 2024
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Asma AyariUniversity of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille (CIIL), Lille, France.
Manuel Rosa-Calatrava *Laboratoire Virologie et Pathologie Humaine - VirPath Team, Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.
Steve Lancel *University of Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, France.
Johanna BarthelemyUniversity of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille (CIIL), Lille, France.
Andrés PizzornoLaboratoire Virologie et Pathologie Humaine - VirPath Team, Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.ORCID http://orcid.org/0000-0002-0918-6804
Alicia Mayeuf-LouchartUniversity of Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, France.
Morgane BaronUniversity of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille (CIIL), Lille, France.
David HotUniversity of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille (CIIL), Lille, France.ORCID http://orcid.org/0000-0002-2361-0616
Lucie DeruyterUniversity of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille (CIIL), Lille, France.
Daphnée SoulardUniversity of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille (CIIL), Lille, France.
Thomas JulienLaboratoire Virologie et Pathologie Humaine - VirPath Team, Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.
Christelle FaveeuwUniversity of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille (CIIL), Lille, France.ORCID http://orcid.org/0000-0002-8373-3992
Olivier Molendi-CosteUniversity of Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, France.
David DombrowiczUniversity of Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, France.
Laura SedanoLaboratoire Virologie et Immunologie Moléculaires (VIM), INRA, Université Paris-Saclay, Jouy-en-Josas, France.
Valentin SencioUniversity of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille (CIIL), Lille, France.ORCID http://orcid.org/0000-0002-6379-4317
Ronan Le GofficLaboratoire Virologie et Immunologie Moléculaires (VIM), INRA, Université Paris-Saclay, Jouy-en-Josas, France.ORCID http://orcid.org/0000-0002-2012-0064
François TrotteinUniversity of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille (CIIL), Lille, France.
Isabelle WolowczukUniversity of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille (CIIL), Lille, France. isabelle.wolowczuk@pasteur-lille.fr.ORCID http://orcid.org/0000-0001-6692-6904
Centre National de la Recherche Scientifique · FRInserm · FRUniversité Claude Bernard Lyon 1 · FRUniversité Paris-Saclay · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Like all obligate intracellular pathogens, influenza A virus (IAV) reprograms host cell's glucose and lipid metabolism to promote its own replication. However, the impact of influenza infection on white adipose tissue (WAT), a key tissue in the control of systemic energy homeostasis, has not been yet characterized. Here, we show that influenza infection induces alterations in whole-body glucose metabolism that persist long after the virus has been cleared. We report depot-specific changes in the WAT of IAV-infected mice, notably characterized by the appearance of thermogenic brown-like adipocytes within the subcutaneous fat depot. Importantly, viral RNA- and viral antigen-harboring cells are detected in the WAT of infected mice. Using in vitro approaches, we find that IAV infection enhances the expression of brown-adipogenesis-related genes in preadipocytes. Overall, our findings shed light on the role that the white adipose tissue, which lies at the crossroads of nutrition, metabolism and immunity, may play in influenza infection.

Indexed as

Energy MetabolismThermogenesisAdipose Tissue, BrownAdipose Tissue, WhiteAnimalsDisease Models, AnimalHumansInfluenza, HumanMaleMiceMice, Inbred C57BLOrthomyxoviridae Infections

Identifiers

PMID32409640
PMCPMC7224208
OpenAlexW3025037183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.